Archive - September 2019
NICE delivers final ‘no’ for Novartis’ migraine treatment Aimovig
Acacia eyes February FDA verdict for refiled nausea drug Barhemsys
Innate Pharma and AstraZeneca take monalizumab into phase 3
TMC preps filings for inclisiran after final phase 3 trials hit the mark
A category to cover all areas within medical affairs in MSEA 2019
Hydrogenated Vegetable Oil: Is It Good Or Bad For You?
AI vs. Humans: Are Diagnostic Robots Just ‘As Good’ As Doctors?
UN Report Warns Climate Change Puts LA, Other US Cities At Risk Of Extreme Flooding